SEC 13F Intelligence

Highvista Strategies LLC / XLRN

Highvista Strategies LLC’s Acceleron Pharma Inc Position

Does Highvista Strategies LLC own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 9.8K shares worth $2M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q3 2021
Shares
9.8K
% of Portfolio
+1.11%
Quarters Held
2
position exited

Position History XLRN

Reported value by quarter
Q2 ’21: $775,000Q2 ’21Q3 ’21: $2MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20219.8K$2M+1.11%
Q2 20216.2K$775,000+0.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of XLRN.